Work

Phase I study of weekly albumin-bound paclitaxel (ab-P) plus weekly cetuximab (Cet) plus intensity-modulated radiation therapy (IMRT) in patients with stage III/IVb head and neck squamous cell carcinoma (HNSCC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.6034

Authors: Matthew G. Fury, Eric Jeffrey Sherman, Shyam S. Rao, Suzanne L. Wolden, Stephanie Smith-Marrone, Kenneth K. Ng, Boris Mueller, Daphna Y. Gelblum, Pinaki R. Dutta, James Lee, Ronglai Shen, Sarah Kurz, Nora Katabi, Sofia Haque, Nancy Y. Lee, David G. Pfister

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2600000589

Cites:

Cited by: 2

Related to: 10